MicroRNAs as Key Effectors in the p53 Network

被引:39
|
作者
Goeman, Frauke [1 ]
Strano, Sabrina [1 ]
Blandino, Giovanni [1 ]
机构
[1] Regina Elena Inst Canc Res, Oncogen & Epigenet Unit, Rome, Italy
关键词
TUMOR-SUPPRESSOR P53; RNA-BINDING PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE FEEDBACK LOOP; BREAST-CANCER STEMNESS; MUTANT P53; DOWN-REGULATION; CELL-MIGRATION; REGULATORY NETWORK; POSITIVE FEEDBACK;
D O I
10.1016/bs.ircmb.2017.04.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The guardian of the genome p53 is embedded in a fine-spun network of MicroRNAs. p53 is able to activate or repress directly the transcription of MicroRNAs that are participating in the tumor-suppressive mission of p53. On the other hand, the expression of p53 is under tight control of MicroRNAs that are either targeting directly p53 or factors that are modifying its protein level or activity. Although the most important function of p53 is suggested to be transcriptional regulation, there are several nontranscriptional functions described. One of those regards the modulation of MicroRNA biogenesis. Wild-type p53 is increasing the maturation of selected MicroRNAs from the primary transcript to the precursor MiRNA by interacting with the Microprocessor complex. Furthermore, p53 is modulating the mRNA accessibility for certain MicroRNAs by association with the RISC complex and transcriptional regulation of RNA-binding proteins. In this way p53 is able to remodel the MiRNA-mRNA interaction network. As wild-type p53 is employing MicroRNAs to suppress cancer development, gain-of-function mutant p53 proteins use MicroRNAs to confer oncogenic properties like chemoresistance and the ability to drive metastasis. Like its wild-type counterpart mutant p53 is able to regulate MicroRNAs transcriptionally and posttranscriptionally. Mutant p53 affects the MiRNA processing at two cleavage steps through interfering with the Microprocessor complex and by downregulating Dicer and KSRP, a modulator of MiRNA biogenesis. Thus, Micro-RNAs are essential components in the p53 pathway, contributing substantially to combat or enhance tumor development depending on the wild-type or mutant p53 context.
引用
收藏
页码:51 / 90
页数:40
相关论文
共 50 条
  • [41] Mutant P53 Is a Key Determinant of Ovarian Cancer
    Mullany, Lisa K.
    Ren, Yi
    Marciano, David C.
    Wong, Kwong-Kwok
    King-Crane, Erin R.
    Katsonis, Panagiotis
    Liu, Zhilin
    Lichtarge, Olivier
    Richards, JoAnne S.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [42] Long noncoding RNAs in the p53 network
    Chaudhary, Ritu
    Lal, Ashish
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2017, 8 (03)
  • [43] Understanding and Therapeutic Targeting of the p53 Network
    Bacher, Susanne
    Schmitz, M. Lienhard
    CANCERS, 2023, 15 (18)
  • [44] Mitogenic signaling and the RB/p53 network
    Sherr, Charles J.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [45] Robustness of the p53 network and biological hackers
    Dartnell, L
    Simeonidis, E
    Hubank, M
    Tsoka, S
    Bogle, IDL
    Papageorgiou, LG
    FEBS LETTERS, 2005, 579 (14) : 3037 - 3042
  • [46] Understanding p53 tumour suppressor network
    Panatta, Emanuele
    Zampieri, Carlotta
    Melino, Gerry
    Amelio, Ivano
    BIOLOGY DIRECT, 2021, 16 (01)
  • [47] Understanding p53 tumour suppressor network
    Emanuele Panatta
    Carlotta Zampieri
    Gerry Melino
    Ivano Amelio
    Biology Direct, 16
  • [48] Living with p53, dying of p53
    Aylon, Yael
    Oren, Moshe
    CELL, 2007, 130 (04) : 597 - 600
  • [49] 'Junk' DNA meets the p53 network
    Blattner, Christine
    MOLECULAR SYSTEMS BIOLOGY, 2008, 4 (1)
  • [50] Mechanisms of transcriptional regulation in the p53 network
    Espinosa, Joaquin
    FASEB JOURNAL, 2012, 26